Evidence map›Paper›PMID 40069733›Full record

ArticleBMC public health2025

Stakeholder perceptions of dementia in Colombia: a qualitative study.

Alejandra Guerrero-Barragán, Diego Ivan Lucumi-Cuesta

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alejandra Guerrero-BarragánGlobal Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Diego Ivan Lucumi-CuestaEscuela de Gobierno Alberto Lleras Camargo, Universidad de los Andes, Bogotá, Colombia. di.lucumi@uniandes.edu.co.

Funding

Alzheimer's Association and Alzheimer's Society GBHI ALZ UK-20-640663)
6 · The paper itself

Abstract

backgroundThe global rise in dementia prevalence poses a significant public health challenge, particularly in low- and middle-income countries where resources for diagnosis, treatment, and support are constrained. Addressing this issue, the World Health Organization's 2017-2025 global action plan on dementia envisions a future where dementia is preventable, and individuals with dementia and their caregivers receive dignified support.

methodsUsing a qualitative research design, this study explores stakeholder perspectives on dementia in Colombia, framed by the World Health Organization's global action plan. Semi-structured interviews were conducted with 12 key stakeholders from the academia, government, and the community. Data were analyzed using framework analysis.

resultsThe interviews revealed a lack of recognition and prioritization of dementia as a public health concern in Colombia. Stakeholders expressed consensus on several challenges, including inadequate community awareness, persistent stigma, insufficient services across care levels, a lack of education for healthcare professionals, and a deficit in research characterizing the dementia population. Paradoxically, participants noted a positive trend, indicating growing awareness among both scientific and non-scientific populations.

conclusionsDementia must urgently be recognized as a public health priority in Colombia. The identified barriers underscore the struggles faced by individuals with dementia and their families, emphasizing the critical need for increased community and governmental awareness.

Indexed as

DementiaStakeholder ParticipationColombiaFemaleHumansInterviews as TopicMaleQualitative ResearchSocial StigmaDementiaDementia planPublic healthQualitative researchStakeholders

Identifiers

PMID40069733
PMCPMC11895336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.